HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease.

AuthorsPer Borghammer, Yoshitaka Kumakura, Paul Cumming
JournalArchives of neurology (Arch Neurol) Vol. 62 Issue 9 Pg. 1480; author reply 1480-1 (Sep 2005) ISSN: 0003-9942 [Print] United States
PMID16157762 (Publication Type: Comment, Comparative Study, Letter)
Chemical References
  • fluorodopa F 18
  • Dihydroxyphenylalanine
Topics
  • Corpus Striatum (metabolism, pathology)
  • Dihydroxyphenylalanine (analogs & derivatives, metabolism, pharmacokinetics)
  • Disease Progression
  • Humans
  • Linear Models
  • Parkinson Disease (pathology)
  • Positron-Emission Tomography (methods)
  • Tomography, Emission-Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: